ArticlePloS one2021

Novel dopamine receptor 3 antagonists inhibit the growth of primary and temozolomide resistant glioblastoma cells.

Sarah E Williford et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.